ALNYLAM PHARMACEUTICALS, INC. (ALNY) /
The profitability of ALNYLAM PHARMACEUTICALS, INC. over the past 10 years
Chart ALNYLAM PHARMACEUTICALS, INC.: gross profit, operating income, net income, fiscal 2016–2025 Open the chart →ALNYLAM PHARMACEUTICALS, INC. reported net income of $313.75M in fiscal 2025, the latest fiscal year on file. That year it had gross profit of $3.04B and operating income of $501.58M. It reported a profit in 1 of the 10 years shown, and a loss in fiscal 2016, 2017, 2018, 2019, 2020, 2021, 2022, 2023 and 2024.
Year by year
| Fiscal year | Gross profit | Operating income | Net income |
|---|---|---|---|
| 2025ended Dec 31, 2025 | $3.04B* | $501.58M | $313.75M |
| 2024ended Dec 31, 2024 | $1.94B* | -$176.88M | -$278.16M |
| 2023ended Dec 31, 2023 | $1.56B* | -$282.18M | -$440.24M |
| 2022ended Dec 31, 2022 | $897.24M* | -$785.07M | -$1.13B |
| 2021ended Dec 31, 2021 | $729.28M* | -$708.65M | -$852.82M |
| 2020ended Dec 31, 2020 | $418.67M* | -$828.44M | -$858.28M |
| 2019ended Dec 31, 2019 | $194.69M* | -$939.43M | -$886.12M |
| 2018ended Dec 31, 2018 | $73.11M* | -$814.67M | -$761.5M |
| 2017ended Dec 31, 2017 | $89.91M* | -$500.09M | -$490.87M |
| 2016ended Dec 31, 2016 | — | -$424.59M | -$410.11M |
Fiscal years as ALNYLAM PHARMACEUTICALS, INC. reports them. * Calculated by us from the company's filed figures; — no figure on file. From SEC filings, updated nightly. How each line is read.
More on ALNYLAM PHARMACEUTICALS, INC.
- The revenue of ALNYLAM PHARMACEUTICALS, INC.
- The cash flow of ALNYLAM PHARMACEUTICALS, INC.
- The debt of ALNYLAM PHARMACEUTICALS, INC.
- All of ALNYLAM PHARMACEUTICALS, INC.'s financials, charted
Companies of a similar size
- NTRSNORTHERN TRUST CORP
- WTWWILLIS TOWERS WATSON PLC
- RJFRAYMOND JAMES FINANCIAL, INC.
- MLMMARTIN MARIETTA MATERIALS INC
- HPQHP INC.
Not investment advice. This page shows what ALNYLAM PHARMACEUTICALS, INC. filed with the SEC. Nothing here is a recommendation about any security. Check important figures against the company's own filings.